Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder

Summary

The purpose of this study is to evaluate the safety and efficacy of an 8-week double-masked treatment of tasimelteon or placebo in male and female subjects with Major Depressive Disorder.

Timeline

Start

2011-09

Primary completion

2013-01

Completion

2013-05

Drugs

Indications